CHOICE-ICD: online education and support for people with an implantable cardioverter defibrillator
Official title: To Co-develop and Test an eHealth Intervention to Improve Knowledge, Attitude and Experience in Patients Living With an Implantable Cardioverter Defibrillator
Run by University of Ulster · NCT06667505 · Data updated 2026-11-12
This project will test an online education and support program (CHOICE-ICD) for people awaiting or recently fitted with an ICD and their families to help lower anxiety and improve quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 256 (estimated) |
| Sponsor | University of Ulster Academic / other |
| Locations | 2 sites (Belfast, County Antrim and 1 other locations) |
| Status | Recruiting |
| Started | August 11, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT06667505 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with heart failure who are awaiting or have recently received an ICD (or CRT-D) and have no cognitive impairment and capacity to consent.
✕Probably not a fit
Patients judged by their cardiologist as physically or mentally unsuitable, those lacking capacity to consent, or those without regular caregiver contact or internet access may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
CHOICE-ICD is a co-designed eHealth intervention that combines written information, short patient videos, animations, games/quizzes and a virtual reality application to teach people about living with an ICD. The program was developed with patients, family members, clinicians and an international advisory group, then optimized through user testing. In a pilot randomized design, about 128 patients awaiting or recently implanted with an ICD (or CRT-D) in Belfast and Glasgow will be offered the resource to use for three months alongside usual care. Key outcomes are feasibility and acceptability, including recruitment, consent and randomization rates, and questionnaire completion at baseline, 3 and 6 months to inform a future effectiveness trial.
Why it matters
Potential benefit: If successful, the program could reduce ICD-related anxiety and improve patients' confidence and quality of life by providing accessible, tailored education and support.
How similar studies have gone: Previous education interventions for ICD patients have shown reductions in anxiety and improved quality of life, but the fully integrated eHealth package with VR and interactive elements is novel and has not been tested at scale.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with heart failure awaiting or with an ICD (no time restriction on implantation) * No cognitive impairment Caregivers: * Have contact with the patient at least 5 times per week. * Be physically and mentally capable of participation (self-assessment) Healthcare professionals: * Daily care of patients with heart failure and an implantable cardioverter defibrillator * Involved in the care of a patient using the Choice-ICD intervention Exclusion Criteria: * Patients, judged by their Cardiologist as physically or mentally unsuitable to complete the study. * Patients or caregivers lacking capacity to give consent. * Patients who have known pregnancy * Caregivers who's patient is unwilling to take participate
Where it's running
-
Golden Jubilee National Hospital
Glasgow, United Kingdom Recruiting -
Belfast Health and Social Care Trust
Belfast, County Antrim, United Kingdom Not yet recruiting
Study contacts
- Principal investigator: Loreena M Hill, PhD — Ulster University
- Study coordinator: Loreena M Prof Loreena M Hill, PhD
- Email: l.hill@ulster.ac.uk
- Phone: +44 7841037404
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Upper-extremity exercise options for people with heart failure and implanted devices
This study tests different upper-extremity exercise programs to see which helps people with heart failure and implanted defibrillators or CRT devices improve arm function.
-
Optimal ATP settings for new ICDs in heart disease patients
This trial tests whether Burst or Ramp ATP settings in the VT zone of a new ICD help patients with heart disease.
-
Belgian registry for extravascular ICDs to track real-world use
This Belgian registry follows adults with extravascular ICDs to see how the devices perform and what issues arise over time in routine care.
-
Carvedilol versus metoprolol succinate in people with heart failure and an implanted defibrillator
This study will test whether switching from metoprolol succinate to carvedilol reduces ICD therapies, heart-related hospitalizations, or cardiovascular death in adults with HFrEF and an ICD.
-
Personalized VT ablation using high-precision heart mapping
This study tests a combined non-invasive and invasive heart-mapping approach to guide VT ablation in adults with structural heart disease and prior VT or ICD therapies.
-
BIOTRONIK CSP Lead Registry for Left Bundle Branch Area Pacing
This registry tests BIOTRONIK’s CSP-based pacing lead in patients needing a pacemaker or CRT, to see how it performs in real-life use.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.